You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 7, 2025

Details for Patent: 10,570,142


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,570,142 protect, and when does it expire?

Patent 10,570,142 protects UKONIQ and is included in one NDA.

This patent has fifty-three patent family members in thirty countries.

Summary for Patent: 10,570,142
Title:Selective PI3K delta inhibitors
Abstract:The present invention relates to selective inhibitors of PI3K delta protein kinases, methods of preparing them, pharmaceutical compositions containing them and methods of treatment and/or prevention of kinase mediated diseases or disorders with them.
Inventor(s):Swaroop K. VAKKALANKA, Meyyappan Muthuppalaniappan, Dhanapalan Nagarathnam
Assignee:Rhizen Pharmaceuticals SA
Application Number:US16/109,337
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,570,142

Introduction

When analyzing a U.S. patent, it is crucial to understand the scope and claims of the patent, as these elements define the invention and its legal boundaries. This article will delve into the specifics of United States Patent 10,570,142, using general principles and tools available for patent analysis.

What is a Patent?

A patent is a form of intellectual property that grants the patent holder the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[1].

Patent Claims

Patent claims are the most critical part of a patent as they define the scope of the invention. Claims are statements that describe the invention and distinguish it from prior art. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim[3].

Analyzing Patent 10,570,142

To analyze the scope and claims of United States Patent 10,570,142, one would typically follow these steps:

Step 1: Identify the Patent

First, locate the patent on the USPTO website or through a patent search database. The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) are valuable resources for this purpose[1].

Step 2: Read the Abstract and Description

The abstract provides a brief summary of the invention, while the detailed description explains the invention in full, including drawings and diagrams.

Step 3: Examine the Claims

Carefully read through the claims section. Here, you will find the independent and dependent claims that define the invention. Each claim should be clear and specific, informing those skilled in the art what the invention is and what it does.

Step 4: Understand Claim Dependencies

Dependent claims build upon independent claims, adding additional limitations. Understanding these dependencies is crucial for determining the full scope of the invention.

Step 5: Review Prior Art and Citations

Check the Common Citation Document (CCD) or other resources to see if there are any prior art citations related to the patent. This helps in understanding how the patent office viewed the novelty and non-obviousness of the invention[1].

Tools for Patent Analysis

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices. This can help in understanding the global patent family and any office actions related to the patent[1].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset offers detailed information on claims from U.S. patents and patent applications. This dataset can provide insights into claim-level statistics and document-level statistics, helping in the analysis of patent scope[3].

Public Search Facility and PTRCs

The USPTO Public Search Facility and PTRCs offer trained staff and resources to assist in patent searches and analysis. These facilities can provide access to patent and trademark information in various formats[1].

Legal Considerations

Claim Construction

Claim construction is a critical legal aspect of patent analysis. It involves interpreting the meaning of the claims, which is a question of law reviewed de novo on appeal. The court's construction of claim terms can significantly impact the validity and infringement analysis of a patent[2].

Validity and Infringement

Patents are accompanied by a presumption of validity, but this can be challenged through inter partes review (IPR) or other legal proceedings. Understanding the validity and potential infringement issues is essential for assessing the strength of a patent[2].

Case Studies and Litigation

Analyzing patent litigation cases can provide valuable insights into how courts interpret patent claims and scope. For example, the case of Vascular Solutions LLC v. Medtronic, Inc. highlights the importance of claim construction and the role of prior art in determining patent validity[2].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could potentially simplify and reduce the costs associated with patent litigation for smaller entities. This could impact how patent disputes are resolved and the overall patent landscape[5].

Key Takeaways

  • Patent Claims: The claims section is the heart of a patent, defining the scope and boundaries of the invention.
  • Tools for Analysis: Utilize resources like the Global Dossier, Patent Claims Research Dataset, and Public Search Facility to gain a comprehensive understanding of the patent.
  • Legal Considerations: Claim construction, validity, and infringement are critical legal aspects that can significantly impact the strength and enforceability of a patent.
  • Litigation: Analyzing patent litigation cases can provide insights into how courts interpret patent claims and scope.

FAQs

Q: What is the purpose of the claims section in a patent?

A: The claims section defines the scope and boundaries of the invention, distinguishing it from prior art and specifying what the patent holder has the right to exclude others from making, using, or selling.

Q: How can I access the file history of a patent?

A: You can use the Global Dossier service, which provides access to the file histories of related applications from participating IP Offices[1].

Q: What is the significance of claim construction in patent law?

A: Claim construction is the process of interpreting the meaning of the claims, which is a question of law reviewed de novo on appeal. It is crucial for determining the validity and infringement of a patent[2].

Q: What is the role of the USPTO Public Search Facility in patent analysis?

A: The USPTO Public Search Facility provides public access to patent and trademark information in various formats, including online, microfilm, and print, and offers trained staff to assist in patent searches and analysis[1].

Q: How does the Patent Claims Research Dataset help in patent analysis?

A: The dataset provides detailed information on claims from U.S. patents and patent applications, including claim-level statistics and document-level statistics, which can help in understanding the scope and trends of patent claims[3].

Sources

  1. USPTO: "Search for patents - USPTO"
  2. CAFC: "VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC."
  3. USPTO: "Patent Claims Research Dataset"
  4. GAO: "Assessing Factors That Affect Patent Infringement Litigation Could ..."
  5. ACUS: "U.S. Patent Small Claims Court"

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,570,142

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 DISCN Yes No 10,570,142 ⤷  Try for Free Y Y RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (FL) WHO HAVE RECEIVED AT LEAST THREE PRIOR LINES OF SYSTEMIC THERAPY ⤷  Try for Free
Tg Theraps UKONIQ umbralisib tosylate TABLET;ORAL 213176-001 Feb 5, 2021 DISCN Yes No 10,570,142 ⤷  Try for Free Y Y RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (MZL) WHO HAVE RECEIVED AT LEAST ONE PRIOR ANTI-CD20-BASED REGIMEN ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,570,142

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 091677 ⤷  Try for Free
Australia 2013285081 ⤷  Try for Free
Brazil 112014033055 ⤷  Try for Free
Canada 2876995 ⤷  Try for Free
Chile 2014003511 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.